Inspiration Healthcare Group plc (AIM: IHC), the UK-based global medical technology company specialising in neonatal intensive care devices, has announced it will present at the Mello2026 investor event in London on Tuesday 17 November. Chief Executive Officer Raffi Stepanian and Chief Financial Officer Alan Olby will deliver two sessions during the day, offering an overview of the company and its strategy. The company has confirmed that no new information will be disclosed at the event, with a PDF of the presentation to be made available on its website following the sessions.

Key Points

  • Inspiration Healthcare Group plc (AIM: IHC) is a UK-headquartered global medical technology company focused on neonatal intensive care.
  • CEO Raffi Stepanian and CFO Alan Olby will present at the Mello2026 investor conference on 17 November at The Clayton Hotel & Conference Centre, Chiswick High Road, London.
  • Presentations are scheduled for 11:15am and 14:25pm; no new financial disclosures or guidance are expected at the event.
  • Investors may wish to monitor the company's website for the published presentation PDF following the event.

Raffi Stepanian and Alan Olby to Address Investors at Two Mello2026 Sessions

Inspiration Healthcare's two most senior executives will take to the stage at the Mello2026 conference, with CEO Raffi Stepanian and CFO Alan Olby presenting at 11:15am and 14:25pm respectively on 17 November. The venue is The Clayton Hotel & Conference Centre on Chiswick High Road, London, W4 5RY. The announcement explicitly states that no new information will be disclosed during the sessions; the presentations will instead provide an overview of the company and its strategic direction, consistent with the company's existing public disclosures. A PDF of the presentation will be published on Inspiration Healthcare's investor relations page at inspirationhealthcaregroup.com following the event.

Neonatal Intensive Care Focus and Global Distribution Underpin IHC's Business Model

Inspiration Healthcare designs, manufactures, and markets medical technology with a specialisation in neonatal intensive care devices, targeting some of the most clinically vulnerable patients from the earliest moments of life. Its own-branded product portfolio spans capital equipment including ventilators for life support through to single-use disposables. The company sells directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes advanced infusion therapy technologies, while an established network of distribution partners provides access to more than 75 countries globally, according to the announcement.

UK Manufacturing Base in Croydon and US Facility in Florida Support International Reach

The company operates its world-class Manufacturing and Technology Centre in Croydon, South London, complemented by a facility in Melbourne, Florida, in the United States. This dual-site operational structure supports both its direct UK and Ireland sales model and its broader international distribution network. Singer Capital Markets acts as nominated adviser and broker, with Cavendish Capital Markets serving as joint broker, reflecting the company's AIM-listed status and its ongoing engagement with the investment community through events such as Mello2026.

No New Guidance Expected; Presentation to Be Published Online After the Event

Investors attending or monitoring the Mello2026 event should note the company's explicit confirmation that no material new information will be released during the presentations. The sessions are intended to provide context and strategic overview for existing and prospective shareholders rather than to announce operational updates or financial guidance. Those unable to attend in person can access further details on the conference through the Mello Events website, while the presentation slides will be made publicly available through Inspiration Healthcare's official news and presentations section at inspirationhealthcaregroup.com.